Advertisement
Home »

Continuous Levodopa/Carbidopa Infusion Shows Favorable Efficacy, Safety

May 15, 2023

REFERENCES & ADDITIONAL READING

Ellenbogen AL, et al. Safety and efficacy of continuous subcutaneous levodopa/carbidopa infusion for Parkinson’s disease. Three-year data from the open-label BeyoND study. Session PL4.003, AAN 2023 Annual Meeting, 22–27 April, Boston, USA.

Poewe W, et al. Mov Disord 2021;36(11):2687–92.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement